Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

18
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
18
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

21
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
21
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

18
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
18
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

10
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
10
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

42
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diffuse Large B-cell Lymphoma Associated With Exposure to Agent Orange.

Cureus·2026
Same author

Outcomes of a penicillin allergy de-labelling implementation intervention in a UK hospital: a prospective, single centre, type 2 hybrid effectiveness-implementation study evaluated using mixed methods.

Implementation science communications·2026
Same author

Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and Mortality.

JACC. Heart failure·2026
Same author

What are patients' and healthcare professionals' views on managing penicillin allergy? A qualitative evidence synthesis.

JAC-antimicrobial resistance·2026
Same author

'ESCMID clinical guidelines on the evaluation and management of a reported antibiotic allergy'-author's reply.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy.

Stem cell reports·2026

Related Experiment Video

Updated: Aug 7, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

15.9K

Infective endocarditis: Do we have an effective risk score model? A systematic review.

Victoria Rizzo1, Mohammad Yousuf Salmasi2, Michael Sabetai1

  • 1Cardiothoracic Surgery, St. Thomas Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

Frontiers in Cardiovascular Medicine
|March 9, 2023
PubMed
Summary

Current infective endocarditis (IE) risk scores show poor external validation, limiting their clinical use. Future research needs larger studies and registries for reliable IE outcome prediction and intervention guidance.

Keywords:
cardiac surgeryendocarditisoutcome assessmentrisk factorsrisk score

More Related Videos

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.0K
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.1K

Related Experiment Videos

Last Updated: Aug 7, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

15.9K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.0K
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.1K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Informatics

Background:

  • Infective endocarditis (IE) is a severe condition with high mortality and surgical rates.
  • Predicting patient outcomes and guiding interventions for IE remains challenging.
  • Existing IE risk scores lack consistent validation and transportability.

Approach:

  • A systematic review following PRISMA guidelines evaluated available IE risk scores.
  • 32 papers analyzing 20 distinct risk scores were included, with a focus on performance metrics like AUC/ROC.
  • Risk-of-bias assessment was conducted using PROBAST guidelines.

Key Points:

  • 14 scores were specific to IE, with variable numbers of predictors (3-14).
  • Many scores performed well in derivation cohorts but poorly in external validation cohorts.
  • Few scores incorporated microbiological variables (50%) or biomarkers (15%).

Conclusions:

  • Current IE risk scores are limited by small sample sizes, retrospective data, and inadequate external validation.
  • The transportability of existing scores is compromised, hindering widespread clinical application.
  • Development of robust IE risk prediction models requires large-scale population studies and comprehensive registries.